🇺🇸 FDA
Pipeline program

HT-001 2% Topical Gel

CLEER-001

Phase 2 small_molecule active

Quick answer

HT-001 2% Topical Gel for Acneiform Eruption Due to Chemical is a Phase 2 program (small_molecule) at Hoth Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Hoth Therapeutics
Indication
Acneiform Eruption Due to Chemical
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials